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The Drosophila immune system discriminates between different classes of infectious microbes and responds
with pathogen-specific defense reactions through selective activation of the Toll and the immune deficiency
(Imd) signaling pathways. The Toll pathway mediates most defenses against Gram-positive bacteria and
fungi, whereas the Imd pathway is required to resist infection by Gram-negative bacteria. The bacterial
components recognized by these pathways remain to be defined. Here we report that Gram-negative
diaminopimelic acid–type peptidoglycan is the most potent inducer of the Imd pathway and that the Toll
pathway is predominantly activated by Gram-positive lysine-type peptidoglycan. Thus, the ability of
Drosophila to discriminate between Gram-positive and Gram-negative bacteria relies on the recognition of
specific forms of peptidoglycan.
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The Drosophila immune system detects
bacteria through specific peptidoglycan
recognition
The innate immune response is activated by receptors that recognize
microbial surface determinants that are conserved among microbes but
are absent in the host, such as lipopolysaccharide (LPS), peptidoglycan
and mannan1. On recognition, these receptors activate signaling cas-
cades that regulate the transcription of target genes encoding regulator
and effector molecules. A transcription profile specific to one class of
pathogen can be achieved when recognition receptors are linked to dis-
tinct signaling pathways.
Drosophila lacks an adaptive immune system and relies solely on
innate immune reactions for its defense2,3. A hallmark of the Drosophila
immune response is the synthesis by the fat body of several antimicro-
bial peptides with distinct but overlapping specificity. These peptides
are secreted into the hemolymph, where they directly kill invading
microorganisms. Genetic analyses show that antimicrobial peptide
genes are regulated by the Toll and Imd pathways. These two pathways
share many common features with the mammalian Toll-like receptor
(TLR) and tumor necrosis factor-α (TNF-α) receptor signaling cas-
cades that regulate NF-κB transcription factors3,4. Each of these path-
ways leads to the activation of specific NF-κB transactivators, which in
turn activate specific programs of transcription5,6.
The Toll pathway is triggered by the proteolytic cleavage of the Toll
ligand Spätzle (Spz) and leads to activation of two Rel proteins, Dorsal
immune-related factor and Dorsal. This pathway is activated mainly by
Gram-positive bacteria and fungi, and it largely controls the expression
of genes encoding antimicrobial peptides (such as Drs, which encodes
drosomycin) that are active against fungi7–11. In contrast, the Imd pathway
responds mainly to Gram-negative bacterial infection, and it controls the
expression of genes encoding antibacterial peptides (such as Dpt, encod-
ing diptericin) through activation of another Rel protein, Relish (encod-
ed by Rel)8,12. Thus, the control of antimicrobial peptide genes by the Toll
and Imd pathways provides a good model of the regulation of innate
immune responses in animals and shows how two distinct signaling path-
ways can generate complex transcriptional patterns in response to differ-
ent pathogens.
Microbial recognition acting upstream of the Toll and Imd pathways
is achieved, at least in part, through peptidoglycan recognition pro-
teins (PGRPs). These proteins bind to peptidoglycan, a component of
the bacterial envelope, and are found in many species including insects
and mammals13,14. Thirteen PGRPs have been identified in
Drosophila15, of which three are currently implicated in the immune
response. PGRP-SA, an extracellular recognition factor, activates the
Toll pathway in response to Gram-positive bacterial but not fungal
infection16. PGRP-LC, a putative transmembrane protein, acts
upstream of the Imd pathway17–19. PGRP-LE, a secreted PGRP, can
activate the Imd pathway when overexpressed in flies, although deter-
mination of its exact function in the Drosophila immune response
awaits loss-of-function analysis20.
Despite the identification of some of the recognition proteins acting
upstream of the Toll and Imd pathways, the microbial compounds that
are recognized by the Drosophila immune system during the course of
an infection have not been characterized. All of the genetic studies
showing that the Imd pathway responds to Gram-negative bacterial
infection and that the Toll cascade defends against Gram-positive bac-
teria and fungi7–11 have been done with live bacteria.
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The presence of lipopolysaccharide (LPS) exclusively on the surface
of Gram-negative bacteria has led to the assumption that LPS recogni-
tion by the fly immune system is a key step in discriminating between
Gram-negative and Gram-positive bacteria. To test this assumption, we
have purified components of various bacterial extracts and assayed
their ability to induce the Toll and Imd pathways. Here we report that
the ability of Drosophila to discriminate between Gram-positive and
Gram-negative bacteria is not based on the detection of LPS but rather
on the recognition of specific forms of peptidoglycan.
Results
LPS does not induce Dpt expression in vivo
The Dpt gene encodes an antibacterial peptide secreted by the fat body
in response to bacterial infection. This gene is tightly regulated by the
Imd pathway, and its expression profile provides an accurate readout
of Imd pathway activity. To elucidate the microbial determinants that
activate the Imd pathway, we purified components of various bacteri-
al extracts and used a glass needle to inject them into the body cavities
of adult flies carrying a Dpt-lacZ transgene. β-Galactosidase activity
generated by the reporter gene was measured in whole flies collected
6 h after challenge. Because the injection procedure creates an injury
that by itself triggers significant induction of the Dpt gene, we com-
pared all β-galactosidase activities to those obtained after control
injections of water (Methods).
One of the most potent activators of vertebrate innate immune
responses is LPS, a principal component of the Gram-negative bacteri-
al outer envelope21,22. Several previous studies have shown that com-
mercial LPS preparations induce the expression of antibacterial peptide
genes in Drosophila23,24; however, our injections of highly purified LPS
from two Gram-negative bacteria, Salmonella typhimurium and
Escherichia coli, did not stimulate the expression of Dpt-lacZ as com-
pared with control water injections (Fig. 1a).
In contrast, the same LPS preparations efficiently activated mouse
macrophages through a TLR4-dependant pathway (data not shown).
Figure 1. Gram-negative peptidogly-
can (PG) activates the Imd pathway.
(a) Induction of the Dpt-lacZ reporter gene
after injection of bacterial components.
Purified bacterial components were inject-
ed into female adult flies carrying a Dpt-
lacZ reporter gene. β-Galactosidase activi-
ty was measured in four flies collected 6 h
after challenge and normalized to the value
obtained after injection of water (set at
100%). Bars represent the mean ± s.d. of
four independent experiments. Flies were
injected with commercial LPS, purified LPS
extracted from E. coli or S. typhimurium, or
purified PG from E. coli (G−), P. aeruginosa PAO1 (G−), B. thuringiensis (G+), B. subtilis (G+), E. faecalis (G+) or M. luteus (G+).As a positive control, flies were injected with increas-
ing concentrations (measured by optical density; OD) of an overnight suspension of E. coli (1106) or P. aeruginosa (PAO1).This experiment was repeated twice with similar
results. (b) Time course of Dpt gene expression after injecting Gram-negative PG. Quantitative real-time PCR analysis was done on total RNA extracts from Oregon wild-
type female flies collected at the indicated intervals after injecting water or 60 µg/ml of E. coli (1106) PG.This experiment was repeated twice with similar results. (c) Effect
of the ∆lpp mutation on the ability of E. coli to induce Dpt. β-Galactosidase activity was measured in females carrying the Dpt-lacZ gene collected 6 h after challenge with
either a needle dipped in a concentrated pellet (OD 100) of E. coli (BW25113) or ∆lpp E. coli (left) or with 60 µg/ml of PG extracted from E. coli (BW25113) or ∆lpp E. coli
(right). C, unchallenged flies. (d) LPS and Gram-negative PG do not activate Dpt synergistically. Flies were injected with purified LPS, purified LPS plus Gram-negative PG, or
commercial LPS from E. coli. PG was extracted and purified from E. coli (1106), and LPS was extracted and purified from E. coli (0111B4).
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Table 1. Induction of Dpt-lacZ after injecting DAP-type 
peptidoglycan preparations
Solution Control1 Peptidoglycan1 P value2
E. coli peptidoglycan 10.2 (38, 3.8) 23.5 (59, 6.5) <10−9
P. aeruginosa peptidoglycan 10.4 (16, 3.6) 20.7 (28, 4.7) <10−3
B. thuringiensis peptidoglycan 10.6 (6, 5.1) 18.0 (24, 6.1) <10−2
1Results are the mean (number of repeats, s.d.) of Dpt-lacZ activity obtained from
adult females injected with water (control) or 50 µg/ml of the peptidoglycan prepa-
ration listed on the left.The result obtained with unchallenged adults was 0.9 (22,
1). 2Value obtained with a t-test. Statistical analysis was done on raw data (without
normalization).
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Experiments with LPS extracted from a nonenterobacterial Gram-neg-
ative bacteria (Bordetella pertussis) produced similar results (data not
shown). In agreement with previous results24, however, injection of
commercial LPS activated the Dpt reporter gene (Fig. 1a). These
results suggest that LPS is not the main determinant for recognition of
Gram-negative bacteria in flies and that, as previously reported25, com-
mercial LPS preparations are contaminated by additional bacterial
components (see below).
Dpt is induced by Gram-negative peptidoglycan
As PGRP-LC is reported to be a putative transmembrane receptor that
functions upstream of the Imd pathway17–19, we tested the effect of puri-
fied peptidoglycan on expression of Dpt-lacZ. We extracted and puri-
fied peptidoglycan from two Gram-negative bacteria (E. coli 1106 and
Pseudomonas aeruginosa PAO1).
Injection of these Gram-negative bacteria–derived peptidoglycans
strongly induced expression of the Dpt-lacZ gene (Fig. 1a): the stimula-
tory effect was detected in flies injected with a solution of 5 µg/ml of
peptidoglycan and reached a maximum at about 50 µg/ml of peptidogly-
can. The expression of Dpt-lacZ induced by these peptidoglycan injec-
tions was 2–5 times higher than that induced by control water injections
(Fig. 1 and Table 1). The difference in the induction from one experiment
to another was due to the injection procedure (Methods). But the stimu-
latory effects of Gram-negative peptidoglycans were statistically signifi-
cant (Table 1) and were similar to the induction observed with live E. coli
or P. aeruginosa under the same injection conditions (Fig. 1a). Injecting
more than 500 µg/ml of peptidoglycan induced less expression of Dpt-
lacZ, a trend that we also observed after injecting increasing amounts of
a concentrated pellet of E. coli and P. aeruginosa (Fig. 1a).
We corroborated our results from the Dpt-lacZ reporter gene assays
by quantitative real-time polymerase chain reaction (PCR) analysis of
Dpt expression. Dpt expression increased three- to fivefold after 
injection of Gram-negative peptidoglycan as compared with injection
of water (Fig. 1b). The induction of Dpt gene was similar to the expres-
sion kinetics observed after injections with live E. coli7, although E.
coli induced higher expression of Dpt at later time points (Fig. 1b).
Lipoproteins are also major components of the Gram-negative bac-
terial cell wall. In E. coli only one lipoprotein, Lpp, is known to be
covalently bound to peptidoglycan26. The Gram-negative peptidoglycan
preparations that we used were extracted and purified by a procedure
that removes all of the proteins associated with peptidoglycan except
for two amino acids, lysine and arginine, at the carboxy terminus of the
E. coli Lpp lipoprotein that remain bound to some diaminopimelic
(DAP) residues of the purified peptidoglycan backbone27. To determine
whether the Dpt induction that we observed after peptidoglycan injec-
tions was caused by Lpp contamination, we generated an E. coli strain
lacking the lpp gene (∆lpp). The Dpt-lacZ reporter gene was induced to
the same extent after injections of live wild-type E. coli and the live
∆lpp mutant (Fig. 1c). Purified peptidoglycans extracted from both of
these strains also induced similar expression of Dpt-lacZ, confirming
that the stimulatory effect of our preparation was due only to peptido-
glycan (Fig. 1c).
Although purified LPS alone did not induce Dpt-lacZ expression, we
considered that LPS and Gram-negative bacterial peptidoglycan might
interact synergistically to induce Dpt. In addition, it has been proposed
that PGRP-LC might bind to both peptidoglycan and LPS as part of a
recognition complex17. To test this possibility, we monitored Dpt-lacZ
expression after injecting solutions containing both Gram-negative bac-
terial peptidoglycan and increasing amounts of highly purified LPS.
The addition of LPS did not increase the peptidoglycan-induced
expression of Dpt-lacZ (Fig. 1d).
Gram-negative peptidoglycan activates the Imd pathway
To determine whether the induction of Dpt expression by Gram-neg-
ative peptidoglycan is mediated by the Imd pathway, we injected
Gram-negative peptidoglycan into flies carrying mutations affecting
components of this pathway: key1 is a modification in kenny, which
encodes the IKKγ subunit of the Drosophila IKK complex, and
PGRP-LC∆E is a mutation in PGRP-LC, which encodes a putative
receptor in the Imd cascade10,17–19. Induction of Dpt-lacZ expression
by Gram-negative peptidoglycan was completely abolished in both
key1 and PGRP-LC∆E flies (Fig. 2a).
Figure 2. Gram-negative peptidoglycan (PG) induces Dpt expres-
sion via the Imd pathway. (a) β-Galactosidase activity in wild-type and
mutant flies carrying the Dpt-lacZ reporter gene after injection with water
or 60 µg/ml of E. coli (1106) PG. (b) Quantitative real-time PCR analysis was
done with total RNA extracts from wild-type and mutant females after
injection with water or 60 µg/ml of E. coli (1106) PG. Flies with mutations
affecting the Toll pathway (spzrm7 and PGRP-SAseml), the Imd pathway (key1,
PGRP-LC∆E and relishE20) or both pathways (relE20;spzrm7) were collected for
analysis 6 h after injection.0
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Figure 3.Muramidase-
treated peptidoglycan
(PG) does not acti-
vate antimicrobial
peptide genes. (a,b)
β-galactosidase activity
was measured in adult
female flies carrying a
Dpt-lacZ reporter gene
collected 6 h after
injecting 60 µg/ml of E.
coli or P. aeruginosa PGs (a) or commercial LPS (b). (c) β-galactosidase activity was measured in adult females carrying a Drs-lacZ reporter gene collected 18 h after injec-
tion of 5 mg/ml of M. luteus or E. faecalis PG. Before injection, the PGs and LPS were incubated overnight at 37 °C in 20 mM sodium phosphate buffer (pH 6.0) in the
absence (incubated) or presence (digested) of muramidase.
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In contrast, spzrm7, a mutation in spz, which encodes the putative lig-
and of the Toll receptor, and PGRP-SAseml, a mutation in PGRP-SA,
which encodes a recognition protein that activates the Toll pathway in
response to Gram-positive bacterial infection16, did not affect Dpt-lacZ
induction by Gram-negative PG (Fig. 2a). We obtained the same results
when we used quantitative real-time PCR to assay the endogenous Dpt
transcript (Fig. 2b). In addition, the Dpt gene was not induced by
Gram-negative peptidoglycan in relE20 or relE20;spzrm7 flies. These exper-
iments confirm that Dpt induction by Gram-negative peptidoglycan is
mediated exclusively by the Imd pathway.
Dpt is induced by peptidoglycan from Bacillus species
The only Gram-positive bacterial species that are known to induce Dpt
expression in Drosophila are members of the Bacillus genus7. To deter-
mine whether the differential activation of the Imd pathway by Gram-
positive species is determined by differences in their peptidoglycan
composition, we injected Dpt-lacZ flies with peptidoglycan purified
from various Gram-positive bacteria.
Injections of peptidoglycan extracted from either Micrococcus luteus
or Enterococcus faecalis did not induce expression of Dpt-lacZ as com-
pared with water injection (Fig. 1a). In contrast, peptidoglycan from
Bacillus subtilis or Bacillus thuringiensis induced the expression of
Dpt-lacZ to almost the same level induced by Gram-negative peptido-
glycans (Fig. 1a, Table 1).
These results confirm previous observations that Bacillus species
induce Dpt expression7 and indicate that this induction is due to a char-
acteristic property of Bacillus peptidoglycan.
Muramidase-treated peptidoglycan does not induce Dpt
The above results indicate that the Imd pathway is activated by a mole-
cular determinant present in Gram-negative bacteria and Bacillus pepti-
doglycans but absent in other Gram-positive peptidoglycans.
Peptidoglycan is a polymer consisting of glycan strands of alternating
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc)
that are crosslinked to each other by short peptide bridges26.
Peptidoglycans from Gram-negative bacteria and Bacillus differ from
other Gram-positive peptidoglycans by the replacement of lysine with a
diaminopimelic acid (DAP) at the third amino acid in the peptide chain.
Thus, our results show that the Imd pathway is induced by the DAP-type
peptidoglycan found in Bacillus and Gram-negative bacterial species but
not by the lysine-type peptidoglycan found in M. luteus and E. faecalis.
It has been shown in mammals that Nod2, a protein involved in intra-
cellular bacterial sensing, recognizes peptidoglycan by detecting a small
peptidoglycan motif, the muramyl-dipeptide (MDP)29,30. To investigate
whether the Imd pathway is also activated through a small peptidogly-
can fragment, we monitored the expression of Dpt-lacZ after injections
of E. coli and P. aeruginosa peptidoglycans that had been digested to
completion with muramidase. The digested peptidoglycan showed a
severely reduced ability to induce the Dpt reporter gene (Fig. 3).
We also used high performance liquid chromatography (HPLC) to
isolate the main compounds (muropeptides) released by the complete
digestion of Gram-negative peptidoglycans with muramidase
(monomers or dimers of disaccharide peptides with tetra- and tripeptide
chains with or without 1,6-anhydro-MurNAc) and determined that
none of them induced Dpt-lacZ expression (data not shown). These
results suggest that polymer chain size, and possibly the three-dimen-
sional organization of the peptidoglycan molecule, has a crucial role in
recognition by the Imd pathway. Commercial LPS treated with
muramidase lost its capacity to induce the Dpt-lacZ gene, indicating
that the activation properties of commercial LPS preparations are
indeed due to peptidoglycan contamination (Fig. 3b).
Taken together, our data indicate that the selective activation of the
Imd pathway by some bacterial strains is linked to the presence of
DAP-type peptidoglycan and, unlike recognition by Nod2 in mammals,
is not mediated through the detection of a small peptidoglycan motif. 
Gram-negative peptidoglycan induces Dpt in mbn-2 cells
The mbn-2 cell line derived from larval hemocytes has been used exten-
sively to study the Drosophila immune response; therefore, we tested
Figure 4. Gram-negative
peptidoglycan (PG) is the
most potent activator of
Dpt in cultured cells.
Drosophila mbn-2 cells were
incubated with the indicated
concentrations of bacterial
components (highly purified
E. coli LPS, P. aeruginosa and M.
luteus PG) for 6 h.Total RNA
was extracted from cells and
Dpt expression was moni-
tored with quantitative fluo-
rescence real-time PCR.
Similar results were obtained
after injecting E. coli PG.
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tive and Gram-neg-
ative peptidoglycans
(PGs) activate the
Toll pathway. (a)
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after injection of bacte-
rial components. β-
Galactosidase activity
was measured in adult
females carrying a Drs-
lacZ reporter gene col-
lected 18 h after chal-
lenge. Flies were inject-
ed with increasing con-
centrations of purified
PG extracted from M. luteus (G+), E. faecalis (G+), E. coli (G−) or P. aeruginosa PAO1 (G−), or purified LPS extracted from E. coli or S. typhimurium.As a positive control, flies
were injected with increasing concentrations of a suspension of M. luteus (G+). This experiment was repeated twice with similar results. (b) Time course of Dpt gene
expression after Gram-positive PG injection. Quantitative real-time PCR analysis of total RNA extracted from wild-type Oregon female flies at the indicated intervals
after injecting water or 5 mg/ml of M. luteus PG.
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whether our bacterial extracts could induce Dpt expression in this cell
line. Highly purified LPS stimulated the Dpt gene, thereby confirming
previous studies reporting that mbn-2 cells respond to LPS23 (Fig. 4).
Also in agreement with previous studies17,23, Gram-positive peptidogly-
can weakly stimulated the expression of Dpt in these cells.
However, mbn-2 cells strongly expressed the Dpt gene when treated
with Gram-negative peptidoglycan: the expression induced by Gram-
negative peptidoglycan was 40 times higher than that induced by LPS
or lysine-type peptidoglycan. These results correlate well with our in
vivo data and confirm that Gram-negative peptidoglycan is the
strongest inducer of the Dpt gene in mbn-2 cells.
Lysine-type peptidoglycans activate the Toll pathway
To determine which bacterial compounds activate the Toll pathway, we
used the same approach described for the Imd pathway but, instead of
using Dpt-lacZ, we monitored the expression of a lacZ reporter construct
for the antifungal peptide gene Drs, which is a target of the Toll path-
way28. We also assayed β-galactosidase activity in the Drs-lacZ flies18 h
after injection because Drs expression peaks later than Dpt expression.
Expression of Drs-lacZ was strongly induced by injections of pepti-
doglycan extracted from M. luteus and E. faecalis, and this induction
increased with the amount of peptidoglycan injected (Fig. 5a). This
result agrees with both previous reports that infections by Gram-posi-
tive bacteria–containing lysine-type peptidoglycans induce Drs expres-
sion7–9 and our current observation that Drs-lacZ expression was pro-
portional to the amount of a concentrated pellet of whole M. luteus bac-
teria injected into flies (Fig. 5a). A time-course study with quantitative
real-time PCR also confirmed that the endogenous Drs gene was
induced more highly after Gram-positive peptidoglycan injection than
after control water injection, and that Drs was induced in an acute-
phase profile that peaked at 24 h (Fig. 5b). As observed for Dpt, the
time course of Drs expression was similar to the kinetics of expression
observed after injections of live M. luteus7–9, although live bacteria
induced higher expression of Drs at later time points, as they did for
Dpt. Gram-positive peptidoglycans also did not induce Drs after they
had been digested to completion with muramidase (Fig. 3c).
Drs induction by lysine-type peptidoglycans was dependant on the
spz and PGRP-SA genes but not on the PGRP-LC and key genes (Fig.
6a). This analysis shows that lysine-type peptidoglycan induces expres-
sion of Drs exclusively through the PGRP-SA–Toll pathway. Our
results are consistent with previous data showing that the Toll pathway
is strongly activated in response to Gram-positive bacterial infection
and that PGRP-SA binds M. luteus peptidoglycan in vitro15.
Gram-negative peptidoglycan weakly activates Toll
The Imd pathway is known to have a crucial role in the response to infec-
tions of Gram-negative bacteria, but we were curious to test whether
microbial compounds from Gram-negative bacteria might also activate
the Toll pathway. The injection of purified LPS injection did not induce
Drs-lacZ expression (Fig. 5a); however, this reporter gene was induced
significantly after the injection of Gram-negative peptidoglycans, albeit
to lower levels than those induced by lysine-type peptidoglycans.
In contrast to Dpt, which is regulated exclusively by the Imd path-
way, Drs is mainly regulated by the Toll pathway but is also partially
induced by the Imd pathway after infections of Gram-negative bacte-
ria8,12. To determine whether Gram-negative peptidoglycan can activate
the Toll pathway, we monitored Drs expression in key1 and PGRP-LC∆E
mutants that have defects in the Imd pathway. Flies were injected with
a solution of 6 mg/ml of Gram-negative peptidoglycan, a dose that
would not stimulate the Imd pathway (Fig. 1a). This procedure allowed
us to monitor the expression of Drs without any input of the Imd path-
way. Quantitative real-time PCR measurements showed that Gram-neg-
ative peptidoglycan induced the Drs gene in PGRP-LC∆E and key1
mutants and that this induction required the spz and PGRP-SA genes,
indicating that the Toll pathway is activated by Gram-negative peptido-
glycan (Fig. 6b).
Discussion
By using highly purified products, we have identified the bacterial
compounds recognized by the Toll and Imd pathways. In contrast to
vertebrates and the invertebrate horseshoe crab, our study suggests that
LPS is not the main determinant for Gram-negative bacterial recogni-
tion in flies. We observed that enterobacterial and nonenterobacterial
purified LPS samples showed no stimulatory effect on expression of the
Dpt gene by the fat body in Drosophila adults.
Purified LPS did induce a weak immune response in the mbn-2 cell
line. The LPS response observed in mbn-2 cells was modest, however,
in comparison with the stimulatory effect of Gram-negative peptido-
glycans. Although we cannot exclude the possibility that the LPS also
has a weak stimulatory effect in vivo that was not detected in our assay,
our results indicate that peptidoglycan is the most active determinant of
Gram-negative bacteria. This finding extends the results of previous
studies showing that peptidoglycan but not LPS activates the prophe-
noloxidase cascade in the silkworm Bombyx mori31,32.
Our study shows that the Imd pathway is activated by specific recog-
nition of Gram-negative and Bacillus peptidoglycans, whereas the Toll
pathway is more responsive to lysine-type peptidoglycans found in
most Gram-positive bacteria. Purified peptidoglycans recapitulate all of
the induction properties of live Gram-negative and Gram-positive bac-
teria, indicating that peptidoglycan is the main bacterial product recog-
nized by the Imd and Toll pathways. Taken together, our results show
that the capacity of the Drosophila immune system to discriminate
between distinct classes of bacteria by the Toll and Imd pathways is
mediated through specific peptidoglycan recognition.
Our data are in keeping with the identification of PGRP-LC and
PGRP-SA as putative receptors of the Imd and Toll pathway16–19. They
suggest that PGRP-LC senses a specific structure that is present in Gram-
negative and Bacillus peptidoglycans but absent in other Gram-positive
Figure 6. Gram-positive and Gram-negative peptidoglycans
(PGs) induce Drs expression via the Toll pathway. Quantitative
real-time PCR analysis of total RNA extracted from wild-type and
mutant females injected with 5 mg/ml of Gram-positive lysine-type
PG extracted from M. luteus (a), or 6 mg/ml of Gram-negative PG
extracted from E. coli (b). Flies carrying mutations affecting the Toll
pathway (spzrm7 and PGRP-SAseml), the Imd pathway (key1, PGRP-LC∆E,
relE20) or both pathways (relE20;spzrm7) were collected for analysis 24 h
after challenge.0
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peptidoglycans, whereas PGRP-SA binds with higher affinity to lysine-
type peptidoglycans than to DAP-type peptidoglycans. These differences
between PGRP-LC and PGRP-SA provide an explanation of why the
Toll pathway is more activated by infections of Gram-positive bacteria
than by infections of Gram-negative bacteria.
Peptidoglycans from Bacillus and Gram-negative bacteria are
crosslinked with a peptide containing a meso-DAP residue, whereas a
lysine is found in the same position on other Gram-positive bacteria33.
This variation probably results in distinct conformational differences,
allowing discriminatory recognition. The observation that Bacillus pep-
tidoglycan is a less potent inducer of the Imd pathway than Gram-
negative peptidoglycan might be explained by the fact that Bacillus
peptidoglycan contains a high proportion of amidated-DAP and only
3% of meso-DAP33. The idea of specific peptidoglycan recognition
through PGRP is supported by the observation that another Drosophila
PGRP, PGRP-LE, binds to DAP-type peptidoglycans but not to lysine-
type peptidoglycans in vitro20.
The stronger activation of the Toll pathway by Gram-positive bacte-
ria with lysine-type peptidoglycan than by Gram-negative bacteria is
probably accentuated during bacterial infection, because activity of the
Toll pathway is proportional to peptidoglycan concentration and Gram-
positive bacterial cell walls contain much more peptidoglycan than do
Gram-negative bacterial cell walls. It is also interesting to note that,
within the range of peptidoglycan concentrations that we tested, maxi-
mum activation of the Imd pathway was reached by using at least 100
times less peptidoglycan than the dose required to strongly activate the
Toll pathway. This finding may reflect the ability of the insect immune
system to recognize Gram-negative bacteria efficiently even though
these bacteria contain less peptidoglycan.
It is surprising that flies can detect Gram-negative bacteria on the
basis of a microbial component that is present at the surface of the inner
membrane and is therefore hidden by the LPS-containing outer mem-
brane. It is possible that the Imd pathway receptor, PGRP-LC, recog-
nizes small amounts of peptidoglycan that are continuously released by
Gram-negative bacteria34. Alternatively, Gram-negative bacteria may be
degraded by humoral or cellular mechanisms that release peptidogly-
can and elicit the antimicrobial response. This latter possibility is sup-
ported by observations that P. aeruginosa cannot initiate the activation
of prophenoloxidase in Galleria mellonela hemolymph unless the bac-
terial cells are damaged35. Our identification of the bacterial molecules
that specifically trigger these two pathways will aid more detailed
analyses of how bacterial elicitors are released and recognized during
the infectious process and how Drosophila mounts specific immune
responses adapted to the type of aggressor.
Two studies have shown that mammalian Nod2 functions as a gener-
al sensor of peptidoglycans through recognition of MDP, the minimal
bioactive peptidoglycan motif that is common to all bacteria29,30. In sup-
port of these studies, peptidoglycan treated with muramidase, an
enzyme that generates small peptidoglycan fragments, induces the
expression of Nod2 in cell culture (S. Girardin, personal communica-
tion). Our observations that after digestion with muramidase neither
Gram-negative nor Gram-positive peptidoglycan activated an immune
response in flies indicate that the bacterial sensing that regulates the
synthesis of antimicrobial peptides by the Drosophila fat body is not
mediated through a small peptidoglycan motif, as it is in the Nod2 sys-
tem. Our study suggests that polymer chain size, and possibly the three-
dimensional organization of the molecule, has a crucial role in bacteri-
al sensing, in agreement with a study showing that the minimum struc-
ture of peptidoglycan required for inducing antibacterial peptides in the
silkworm B. mori is two repeating GlcNAc-MurNAc units with peptide
chains36. We cannot, however, definitively exclude the possibility that
other immune-responsive tissues (such as hemocytes) may respond to
small peptidoglycan fragments.
Our study and the work on mammalian Nod2 indicate that peptido-
glycan is a complex bacterial elicitor and that the innate host defense
has developed several ways to detect peptidoglycan. In vertebrates,
TLR2 has been also implicated in peptidoglycan sensing22,37, but the
precise nature of the peptidoglycan fragment recognized by TLR2 is
not known. It would be worthwhile determining whether vertebrates,
like the fruit fly, use distinct receptors to recognize Gram-negative and
Gram-positive peptidoglycans.
Methods
Fly stocks. ORR, DD1 (y, w, P(ry+, Dpt-lacZ), P(w+, Drs-GFP)) or 8871A (w, P(w+, Drs-
lacZ)) flies were used as wild-type strains38. Dpt-lacZ is a P transgene inserted on the X
chromosome that contains a fusion between 2.2 kilobases (kb) of upstream sequence from
the Dpt gene and the coding sequences from the gene encoding β-galactosidase38. Drs-lacZ
is a P transgene inserted on the X chromosome that contains a fusion between 2.4 kb of
upstream sequence from Drs gene and the coding sequences from β-galactosidase38. The
spzrm7, key1, PGRP-SAseml, PGRP-LC∆E and relE20 alleles have been described8,10,16,18,12,38. We
maintained fly stocks at 25 °C in standard medium.
Injection and lacZ measurements. We injected 9.2 nl of solution (water, bacterial extracts or
overnight bacteria culture) into the thorax of female adults (aged 3–4 d) with a Nanoject appa-
ratus (Drummond, Broomall, PA). After injection, flies were incubated for 6 h (Dpt-lacZ) or
18 h (Drs-lacZ) at 25 °C. Bacterial strains and LacZ measurements were done as described7,38.
Because the injection procedure creates an injury that by itself triggers a significant induction
of the Dpt and Drs reporter genes, we normalized measurements of β-galactosidase activity
after injecting microbial compounds or live bacteria to measurements obtained after injecting
water under the same conditions (needle, time, experimenter). The values obtained after water
injection were arbitrarily set at 100. Subtle changes in the size and sharpness of the needle
affected the expression of Dpt and Drs (a larger needle generally induced higher expression
of antimicrobial peptide genes). This effect explains most of the differences in the stimulation
that we observed from one experiment to another. The effect of injury was less marked at later
time points and consequently had less influence on Drs expression.
Bacterial products and bacterial strains. Commercial LPS (Sigma, St. Louis, MO) from 
E. coli 055:B5 was used either directly or after treatment with muramidase. LPS from E. coli
0111B4, S. typhimurium LT2 and B. pertussis was highly purified. The purification steps
involved the extraction of phospholipids with chloroform/methanol (1:2) followed by treatment
with DNase, RNase and then protease until thin-layer chromatography and ultraviolet spectra
showed no detectable contaminants39. We check the electrophoretic behavior and mass of all
purified samples by SDS-PAGE and mass spectrometry, respectively40. Purified LPS from
S. typhimurium LT2 was used directly, whereas E. coli 0111B4 and B. pertussis LPS were treat-
ed by a procedure that improves LPS solubility by removing divalent cations that form links
between molecules41. This procedure rules out erroneous results arising from aggregation.
Purified peptidoglycans were obtained from cultures of E. coli (1106), P. aeruginosa
(PAO1), M. luteus, E. faecalis, B. thuringiensis and B. subtilis grown overnight at 37 °C in
LB medium. Cultures were stopped by rapid chilling to 0–4 °C. Collected cells were
washed with a cold 0.85% NaCl solution and centrifuged again. We then rapidly suspend-
ed the bacteria with vigorous stirring in 20 ml of a hot (95–100 °C) aqueous solution of 4%
SDS for 30 min. After standing overnight at 20 °C, the suspensions were centrifuged for 30
min at 200,000g in a Beckman TL100 centrifuge and the pellets were washed several times
with water. Final suspensions were made in 2 ml of water and aliquots (100 µl) were
hydrolyzed and analyzed with a Hitachi L8800 amino acid analyzer. The peptidoglycan
content of the sacculi was expressed in terms of its muramic acid content. We treated the
crude preparations successively with pancreatin, pronase and trypsin (Sigma) to eliminate
peptidoglycan-associated proteins27. Hydrolysis of an aliquot of the peptidoglycan prepara-
tions after several washings in water showed that they contained only peptidoglycan con-
stituents, muramic acid, glucosamine, alanine, glutamic acid and diaminopimelic acid or
lysine, in the expected molar ratios.
Peptidoglycans were digested by overnight treatment with the muramidase mutanolysin
(Sigma) and the reaction was stopped by incubating samples in a boiling water bath for 
5 min. We reduced the resulting soluble fragments (muropeptides) with sodium borohydride
and separated them by reverse-phase HPLC as described26. MDP (MurNAc-L-Ala-D-isoGln)
was obtained from Calbiochem (La Jolla, CA) and MurNAc peptides were generated by
mild acid hydrolysis of UDP-MurNAc peptides in 0.1 M HCl for 10 min at 95 °C. The 
E. coli mutant strain BW25113 ∆lpp:CmR, in which the whole lpp gene was replaced with
an antibiotic (chloramphenicol) resistance gene, was created as described42. The oligonu-
cleotides used for PCR amplification of the antibiotic resistance gene flanked by sequences
designed for specific disruption of the lpp gene were 5′-CGC TAC ATG GAG ATT AAC
TCA ATC TAG AGG GTA TTA ATA ATG AAA GCT ACA TAT GAA TAT CCT CCT
TAG-3′ and 5′-GGC GCA CAA TGT GCG CCA TTT TTC ACT TCA CAG GTA CTA TTA
CTT GCG GGT GTA GGC TGG AGC TGC TTC-3′.
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Cell culture and immune stimulations. We maintained Drosophila mbn-2 cells in
Schneider medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum.
For immune stimulation, cells were incubated with different concentrations of bacterial
components (commercial LPS, highly purified LPS from E. coli and highly purified pepti-
doglycan from M. luteus and P. aeruginosa) for 6 h.
Quantitative real-time PCR. Total RNA was extracted with RNAzol reagent (Invitrogen,
Carlsbad, CA). Complementary DNA was synthesized by using the First cDNA synthesis
kit (Roche, Basel, Switzerland) in accordance with manufacturer’s instructions. For quanti-
tative analysis of Dpt expression, fluorescence real-time PCR was done with the double-
stranded DNA dye SYBR Green (Perkin Elmer, Boston MA). Primer pairs for Dpt (sense,
5′-GGC TTA TCC GAT GCC CGA CG-3′; antisense, 5′-TCT GTA GGT GTA GGT GCT
TCC C-3′) and control Rac2 (sense, 5′-CAG ACG ATC GAG AAG CTG AAG G-3′; anti-
sense, 5′-GTG CCG CTT GGG TCC TCG AAC G-3′) were used to detect target gene tran-
scripts. We analyzed SYBR Green with an ABI PRISM 7700 system (Perkin Elmer) in
accordance with the manufacturer’s instructions. All samples were analyzed in triplicate,
and the amount of messenger RNA detected was normalized to control Rac2 mRNA values.
We used normalized data to quantity the relative levels of a given mRNA according to
cycling threshold (∆Ct) analysis.
To quantify Drs and Dpt mRNA in whole animals, we extracted RNA with RNA TRIzol
(Invitrogen). cDNAs were synthesized with SuperScript II (Invitrogen) and PCR was done
with the double-stranded DNA dye SYBR Green I (Roche) Primer pairs for Dpt (sense, 5′-
GCT GCG CAA TCG CTT CTA CT-3′; antisense, 5′-TGG TGG AGT GGG CTT CAT G
-3′), Drs (sense, 5′-CGT GAG AAC CTT TTC CAA TAT GAT G-3′; antisense, 5′-TCC
CAG GAC CAC CAG CAT-3′) and control Rp49 (sense, 5′-GAC GCT TCA AGG GAC
AGT ATC TG-3′; antisense, 5′-AAA CGC GGT TCT GCA TGA G-3′) were used to detect
target gene transcripts. SYBR Green was analyzed on a Lightcycler (Roche).
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